ES2091408T3 - Fermentacion de un acido triol heptanoico por cepas mutantes de aspergillus terreus. - Google Patents

Fermentacion de un acido triol heptanoico por cepas mutantes de aspergillus terreus.

Info

Publication number
ES2091408T3
ES2091408T3 ES92304739T ES92304739T ES2091408T3 ES 2091408 T3 ES2091408 T3 ES 2091408T3 ES 92304739 T ES92304739 T ES 92304739T ES 92304739 T ES92304739 T ES 92304739T ES 2091408 T3 ES2091408 T3 ES 2091408T3
Authority
ES
Spain
Prior art keywords
triol acid
fermentation
aspergillus terreus
acid
heptanoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92304739T
Other languages
English (en)
Inventor
William H Cover
Rebecca L Dabora
Anderson Hong
Christopher Reeves
Robert W Stieber
Victor A Vinci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2091408T3 publication Critical patent/ES2091408T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/66—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE HAN DESCUBIERTO NUEVAS CEPAS DE ASPERGILLUS TERREUS QUE PROPORCIONAN LA PRODUCCION DE LA FERMENTACION DE AL MENOS 5,2 G/L DE ACIDO 7-[1,2,6,7,8,8A(R)-HEXAHIDRO-2(S),6(R)-DIMETIL-8(S)HIDROXI-1(S)-NAFTIL]-3(R),5(R)-DIHIDROXIHEPTANOICO (ACIDO DE TRIOL, I), PERO CON UNA PRODUCCION DE NO MAS DE 0,85 G/L DE PRODUCTOS SECUNDARIOS RELACIONADOS CON EL ACIDO DE TRIOL Y ESPECIFICAMENTE MENOS DE 0,10 MG/LITRO DE LOVASTATINA. EL ACIDO DE TRIOL DEL PRODUCTO DE FERMENTACION PREDOMINANTE SE PUEDE CONVERTIR DE MANERA DIRECTA A SU FORMA DE LACTONA, EN QUE ES UN INHIBIDOR DE LA REDUCTASA DE HMG-COA Y POR TANTO ES UTIL COMO AGENTE ANTIHIPERCOLESTEROLEMICO Y EN QUE TAMBIEN PUEDE SERVIR COMO INTERMEDIO PARA LA PREPARACION DE OTROS INIBIDORES DE LA REDUCTASA DE HMG-COA.
ES92304739T 1991-06-04 1992-05-26 Fermentacion de un acido triol heptanoico por cepas mutantes de aspergillus terreus. Expired - Lifetime ES2091408T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/709,950 US5250435A (en) 1991-06-04 1991-06-04 Mutant strains of Aspergillus terreus for producing 7-[1,2,6,7,8,8a(R)-hexa-hydro-2(S),6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid),I)

Publications (1)

Publication Number Publication Date
ES2091408T3 true ES2091408T3 (es) 1996-11-01

Family

ID=24851974

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92304739T Expired - Lifetime ES2091408T3 (es) 1991-06-04 1992-05-26 Fermentacion de un acido triol heptanoico por cepas mutantes de aspergillus terreus.

Country Status (10)

Country Link
US (1) US5250435A (es)
EP (1) EP0517413B1 (es)
JP (1) JP2611088B2 (es)
AT (1) ATE142253T1 (es)
CA (1) CA2070148C (es)
DE (1) DE69213335T2 (es)
DK (1) DK0517413T3 (es)
ES (1) ES2091408T3 (es)
GR (1) GR3021115T3 (es)
IE (1) IE73237B1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208997B (en) * 1992-06-17 1994-02-28 Gyogyszerkutato Intezet Microbiological method for producing mevinoline
SI9500238A (en) * 1995-07-27 1997-02-28 Krka Tovarna Zdravil Procedure for the production of lovastatin
AU719831B2 (en) * 1995-08-18 2000-05-18 Smk Co., Ltd. Connector plug for automobiles
KR970707616A (ko) * 1995-08-18 1997-12-01 이케다 테루타카 자동차용 커넥터플러그(connector plug for automobiles)
KR100234976B1 (ko) * 1997-08-01 1999-12-15 김충환 세룰레닌 및 엘-메치오닌 유사체에 동시 내성을 갖는 아스퍼질 러스속 미생물 및 그를 이용한 메비놀린산의 제조방법
IL143197A0 (en) 1998-11-20 2002-04-21 Rtp Pharma Inc Dispersible phospholipid stabilized microparticles
WO2001030773A2 (en) 1999-10-27 2001-05-03 Merck & Co., Inc. Lactonization process
KR100342789B1 (ko) 1999-10-29 2002-07-04 김용규 니스타틴에 내성을 갖는 아스퍼질러스속 미생물 및 그를 이용한 트리올 헵타노익산의 제조방법
JP2003513036A (ja) * 1999-11-03 2003-04-08 ハワード ジェイ．スミス アンド アソシエイツ ピーティーワイ リミテッド 肝臓選択的な治療方法
US6849257B2 (en) 2000-02-04 2005-02-01 Children's Hospital Research Foundation Lipid hydrolysis therapy for atherosclerosis and related diseases
WO2002020453A1 (en) * 2000-09-07 2002-03-14 Kaneka Corporation Methods for crystallization of hydroxycarboxylic acids
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
WO2002064809A2 (en) * 2001-02-09 2002-08-22 Unilever N.V. Process for the preparation of one or more statins by fermentation
US6790954B2 (en) 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
DK3072978T3 (en) 2002-05-09 2018-09-17 Brigham & Womens Hospital Inc : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER
EP1585500B8 (en) * 2002-12-20 2017-07-26 Auritec Pharmaceuticals Coated particles for sustained-release pharmaceutical administration
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
EP2927693A1 (en) 2004-10-06 2015-10-07 The Brigham and Women's Hospital Relevance of achieved levels of markers of systemic inflammation following treatment
JP2008528626A (ja) * 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． ヒドロキシル化されたネビボロールを含む薬学的組成物
AU2005332300B2 (en) 2005-05-31 2011-07-07 Mylan Laboratories, Inc. Compositions comprising nebivolol
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
US20080057590A1 (en) 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
US10568860B2 (en) 2006-08-30 2020-02-25 Kowa Co., Ltd. Pharmaceutical composition containing statin-encapsulated nanoparticle
CA2684308A1 (en) 2007-04-18 2008-10-30 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
KR20120139723A (ko) 2010-02-01 2012-12-27 더 호스피탈 포 식 칠드런 재발협착증의 치료 및 예방을 위한 원격 허혈 처치
CA2795053A1 (en) 2010-03-31 2011-10-06 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction
SG10201908576VA (en) 2010-04-08 2019-10-30 Hospital For Sick Children Use of remote ischemic conditioning for traumatic injury
ES2786506T3 (es) 2012-08-01 2020-10-13 Zahra Tavakoli Composiciones congeladas fluidas que comprenden un agente terapéutico
BR112015024234B1 (pt) 2013-03-21 2022-11-16 Eupraxia Pharmaceuticals USA LLC Composição farmacêutica de liberação sustentada injetável, uso da mesma para diminuir inflamação ou controlar dor e método para formar micropartículas revestidas
DK3206672T3 (en) 2015-10-27 2018-06-18 Eupraxia Pharmaceuticals Inc Formulations for sustained release of local anesthetics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
JPS56142236A (en) * 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
US4420491A (en) * 1980-05-28 1983-12-13 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4376863A (en) * 1981-08-21 1983-03-15 Merck & Co., Inc. Hypocholesterolemic fermentation products
US4387242A (en) * 1981-08-21 1983-06-07 Merck & Co., Inc. Hypocholesterolemic fermentation products and process of preparation
JPS6113798A (ja) * 1984-06-28 1986-01-22 Pioneer Electronic Corp スピ−カ用振動板
US4876364A (en) * 1987-09-03 1989-10-24 Merck & Co., Inc. Hydrogenation process for the formation of 4A,5-dihydro HMG-CoA reductase inhibitors
US4916239A (en) * 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof

Also Published As

Publication number Publication date
DK0517413T3 (da) 1996-09-23
CA2070148A1 (en) 1992-12-05
ATE142253T1 (de) 1996-09-15
DE69213335T2 (de) 1997-03-20
IE921801A1 (en) 1992-12-16
IE73237B1 (en) 1997-05-21
EP0517413B1 (en) 1996-09-04
CA2070148C (en) 1999-11-09
JP2611088B2 (ja) 1997-05-21
JPH067176A (ja) 1994-01-18
US5250435A (en) 1993-10-05
DE69213335D1 (de) 1996-10-10
EP0517413A1 (en) 1992-12-09
GR3021115T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
ES2091408T3 (es) Fermentacion de un acido triol heptanoico por cepas mutantes de aspergillus terreus.
AU3585393A (en) Biochemical purification of simvastatin
IL142055A0 (en) New salts of hmg-coa reductase inhibitors
US4517373A (en) IsoMB-530B derivatives
SE8206580L (sv) Framstellning av 3-hydroxi-ml-236b-derivat
TR200101235T2 (tr) HMG-CoA Redüktaz inhibitörü içeren durağan farmasötik formül
IL187261A0 (en) Crystals of the sodium salt of pravastatin
OMURA et al. Potent inhibitory effect of antibiotic 1233A on cholesterol biosynthesis which specifically blocks 3-hydroxy-3-methylglutaryl coenzyme A synthase
YU81800A (sh) POSTUPAK ZA DOBIJANJE INHIBITORA HMG-CoA REDUKTAZE VISOKE ČISTOĆE
CA2053000A1 (en) Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula
AU1510800A (en) Process for the preparation of simvastatin and analogs thereof
IE842592L (en) Preparing pyranones
JP3689429B2 (ja) ロバスタチンの製造方法
Patil et al. Novel acetylenic acids from the root bark of Paramacrolobium caeruleum: inhibitors of 3-Hydroxy-3-methyl-glutaryl Coenzyme A reductase
WO1998012188A3 (en) Process for producing simvastatin
AU547968B2 (en) Ml-236b derivatives i.e. alactone and the corresponding free hydroxy-carboxylic acid
Cover et al. Mutant strains of Aspergillus terreus for producing 7-[1, 2, 6, 7, 8, 8 A (R)-hexa-hydro 2 (S), 6 (R)-dimethyl-8 (S)-hydroxy 1 (S)-naphthyl]-3 (R), 5 (R)-dihydroxyheptanoic acid(triol acid), I
EP0909757A3 (en) Process for producing optically active pentanetetraols

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517413

Country of ref document: ES